Novel agents in the treatment of stable angina.

Authors: Ferreira Lisboa da Silva, RM
In stable angina, added to lifestyle changes and risk factor control, pharmacological treatment aims to reduce risk and symptoms. The novel anti-ischemic drugs ivabradine, nicorandil, ranolazine and trimetazidine have been introduced for more effective symptom control. Review here their specific mechanisms of action and side effects.
Read More

Topics:
Acute Coronary Syndromes (ACS)

Source: ESC News and Press - February 10, 2014 Category: Cardiology Source Type: news